Intimation for Sub-division/Split of Equity Shares
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Titan Biotech's board has approved a sub-division (stock split) of equity shares, where every 1 share with a face value of Rs. 10 will be split into 5 shares with a face value of Rs. 2 each. The company's issued and paid-up share count will increase from 82.63 lakh shares to about 4.13 crore shares, while the total share capital value remains unchanged at around Rs. 8.26 crore. The move is aimed at improving liquidity and making the stock more affordable for retail investors. The split is subject to shareholder approval via postal ballot, with expected completion within about 2 months. The record date for the split will be announced after member approval is obtained.
The face value drop from Rs. 10 to Rs. 2 typically leads to a corresponding reduction in the market price per share, making the stock more accessible to small investors and potentially boosting trading volumes. Total shareholder value remains unchanged, so this is a cosmetic change rather than a value-creating event.